Where does Tempest Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Tempest Therapeutics, Inc. ranks #25,364 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Tempest Therapeutics, Inc. hold?

Tempest Therapeutics, Inc. holds 11 US utility patents granted between 2018 and 2025, spanning 4 technology areas.

What is Tempest Therapeutics, Inc.'s Innovation Score?

Tempest Therapeutics, Inc. has an Innovation Score of 39.9 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Tempest Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Tempest Therapeutics, Inc.'s recent grant velocity is +800% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Tempest Therapeutics, Inc.'s patents?

Tempest Therapeutics, Inc.'s patents average 18.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Tempest Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Tempest Therapeutics, Inc.

Q: What technology areas does Tempest Therapeutics, Inc. focus on?

Tempest Therapeutics, Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 10 patents. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tempest ranks #25,364 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 4 technology areas.

#25,364
of 50,000 US assignees by volume: Top 37%
by Innovation Score (39.9/100): 18.2
avg claims per patent: +800%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25364 · US Corporation #25,364 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #25,364/50,000
PHOTO-FINISH TEKNOWARE OY
CPC-NARROW A61P · 4 areas
INNOV-THIN 39.9/100
CLAIMS-RICH 18.2 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +800% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Teknoware OY (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Tempest Therapeutics · this assignee

40
3D Lighting Innovati… · lowest

7

What this shows Tempest's Innovation Score is 39.9/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Tempest's grants concentrate

Tempest Therapeutics, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 90.9% of grants classified under A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2018. By volume, Tempest sits between Teknoware OY and Tetrasun, Inc..

Tempest's three-year grant acceleration

Tempest Therapeutics, Inc. shows 6 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Teknoware OY

11
Teledyne Dalsa

11
Teleflex LIFE Sci…

11
Telus Communicati…

11
Teoco

11
Tercel IP

11
Terzani S R L

11
Tetrasun

11
Tempest Therapeut… ◀

11

What this shows Tempest holds 11 patents at rank #25,341, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tempest

By rank, the assignees closest to #25,341 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Tempest's primary technology class.

Tempest's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Tempest Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	9.1%
2020	1	9.1%
2021	2	18.2%
2022	2	18.2%
2023	4	36.4%
2025partial year	1	9.1%

Which technologies does Tempest Therapeutics, Inc. patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 10

C07D - HETEROCYCLIC COMPOUNDS 10

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 4

C07K - PEPTIDES 3

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#25,364

of 50,000 tracked assignees

Innovation Score

39.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.